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ARTICLE
Tricellulin Is a Tight-Junction Protein Necessary for Hearing
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The inner ear has ﬂuid-ﬁlled compartments of different ionic compositions, including the endolymphatic and perilym-
phatic spaces of the organ of Corti; the separation from one another by epithelial barriers is required for normal hearing.
TRIC encodes tricellulin, a recently discovered tight-junction (TJ) protein that contributes to the structure and function
of tricellular contacts of neighboring cells in many epithelial tissues. We show that, in humans, four different recessive
mutations of TRIC cause nonsyndromic deafness (DFNB49), a surprisingly limited phenotype, given the widespread tissue
distribution of tricellulin in epithelial cells. In the inner ear, tricellulin is concentrated at the tricellular TJs in cochlear
and vestibular epithelia, including the structurally complex and extensive junctions between supporting and hair cells.
We also demonstrate that there are multiple alternatively spliced isoforms of TRIC in various tissues and that mutations
of TRIC associated with hearing loss remove all or most of a conserved region in the cytosolic domain that binds to the
cytosolic scaffolding protein ZO-1. A wild-type isoform of tricellulin, which lacks this conserved region, is unaffected by
the mutant alleles and is hypothesized to be sufﬁcient for structural and functional integrity of epithelial barriers outside
the inner ear.
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In the inner ear, the endolymphatic and perilymphatic
spaces of the organ of Corti are ﬂuid-ﬁlled compartments
of differing ionic compositions. This strict compartmen-
talization is required for normal hearing1,2 and is accom-
plished by the tight-type tight junctions (TJs) of the re-
ticular lamina, which consists of a mosaic of supporting
cells and sensory hair cells. The apical membranes of the
sensory hair cells and supporting cells are interconnected
by uniquely complex bicellular TJs (bTJs) that are charac-
terized by several parallel strands at the upper part of the
TJ and an extensive labyrinth of irregular TJ strands in the
lower part.3,4 Among the large variety of TJ proteins, two
members of the claudin family have been shown to be nec-
essary for the normal function of the inner ear. Mutations
of claudin 14 cause deafness in humans (DFNB29 [MIM
605608 and 610153]) and mice,5–7 whereas a claudin 11
knockout mouse is also deaf.8,9
In addition to the selective permeability of bTJs, which
helps to maintain the distinct ionic composition of com-
partments separated by epithelial barriers, the passage of
solutes and ions is also assumed to occur through the tri-
cellular region,10–12 which has a unique architecture at the
point where three epithelial cells contact one another.13
Tricellulin was recently described as one of the constitu-
ents of tricellular TJs (tTJs) and perhaps of bTJs of epithelial
barriers in general.13
Elsewhere, we reported two Pakistani families segregat-
ing nonsyndromic hearing loss that was linked tomarkers
on chromosome 5q12.3-q14.1, and we deﬁned an 11-cM
interval for the DFNB49 locus.14 Here, we reﬁned this in-
terval to 2.4 Mb after ascertaining six additional DFNB49-
affected families. Among the numerous candidates in this
reﬁned DFNB49 interval are two genes encoding TJ tetra-
span proteins of epithelial cells: tricellulin and occludin.13,
15 After excluding OCLN and seven other genes in the
DFNB49 interval, we found that mutant alleles of TRIC,
which encodes tricellulin, cosegregatewithnonsyndromic
moderate-to-profound DFNB49. We also show that tricel-
lulin is concentrated in tTJs of mammalian inner-ear ep-
ithelia, including the tricellular junctions of the reticular
lamina of the organ of Corti.
Material and Methods
Subjects
Subjects were enrolled in this study after we obtained their writ-
ten informed consent. Approval was obtained from the National
Institute of Neurological Disorders and Stroke/National Institute
on Deafness and Other Communication Disorders (NIDCD) In-
stitutional Review Board (IRB) at the National Institutes of Health
(NIH), Bethesda (protocol OH-93-N-016) and from the IRB at the
National Centre of Excellence in Molecular Biology, Lahore, Pak-
istan (protocol FWA00001758).
Clinical Evaluation
A general physical examination of all the affected individuals
was conducted. No other clinical problem was found to consis-
Figure 1. DFNB49-affected families segregating hearing loss associated with mutations of TRIC. A, Human pedigrees cosegregating
hearing loss linked to markers in the DFNB49 interval. B, Haplotype of ﬁve STR markers linked to TRIC on chromosome 5 for families
PKDF141 and PKDF340. Family PKDF141 has a maximum 2-point LOD score of 5.82 ( ) for marker D5S589. Individual IV:10 in familyvp 0
PKDF141 has the same disease haplotype and carries the same mutant allele of TRIC as does her spouse, suggesting common ancestry.
Family PKDF340 has a maximum 2-point LOD score of 6.1 ( ) for GATA141B10. Meiotic recombinations deﬁne a linkage interval forvp 0
DFNB49 between D5S629 and D5S637, which, on a physical map, is from 68,311,260 to 71,336,684 bp (UCSC browser; May 2004
assembly). The proximal and distal breakpoints were identiﬁed in deaf individuals V:6 (PKDF141) and VI:2 (PKDF340), respectively. C,
Representative sequence chromatograms of four mutations of TRIC.
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Figure 2. Pure-tone air-conduction averages (0.5, 1, 2, and 4
kHz) for the better-hearing ears of seven of the eight DFNB49-
affected families. The X-axis is age, and the Y-axis is the average
decibel (dBHL) at which the threshold of hearing is detected. There
is inter- and intrafamilial variability in the severity of hearing loss
due to recessive mutations of TRIC, which may be caused by genetic
modiﬁers and/or environmental factors. For control subjects and
normal-hearing members of families, hearing thresholds measured
in ambient-noise conditions were 25–30 dBHL.
Table 1. Family Data, Mutations of TRIC, and Allele
Frequencies
Family LOD at vp 0 Marker
Pathogenic TRIC
Mutation
PKDF399 2.6 D5S647 IVS3-1GrA
PKDF058 2.4 D5S647 IVS42delTGAG
PKDF156 5.8 GATA141B10 IVS42delTGAG
PKDF141 5.8 D5S589 IVS42TrC
PKDF443 1.7 D5S647 IVS42TrC
PKDF462 1.7 GATA141B10 IVS42TrC
PKSR12 1.8 D5S647 IVS42TrC
PKDF340 6.1 GATA141B10 c.1498CrT p.R500X
NOTE.—Nucleotide changes are numbered according to the ﬁrst
coding ATG in exon 2 of TRIC-a. LOD scores were calculated using
parameters described elsewhere.26 Brieﬂy, the disease was coded
as fully penetrant, and the disease-allele frequency was set at
0.001. Meiotic recombination fractions were assumed to be equal
for males and females. The three splice-site mutations of TRIC shown
here were not found in at least 400 control chromosomes. See ﬁgure
3C and 3D for the predicted truncated tricellulin proteins resulting
from each the three frameshifting splice-site mutations.
tently cosegregate with the hearing loss, including any vestibu-
lopathy. An audiometric evaluation was performed on all of the
affected individuals of the DFNB49-affected families by measur-
ing the threshold of hearing at 250–8,000 Hz for pure-tone air
conduction.
Sequencing
All DNA sequencing was performed using an ABI 3730 capillary
instrument as described elsewhere.16
Generation and Growth of Lymphoblastoid Cell Lines
Lymphoblastoid cell cultures were established by the Coriell In-
stitute, National Institute of General Medical Sciences Human
Genetic Cell Project (NJ), through Epstein-Barr–virus transforma-
tion of peripheral-blood samples from deaf subjects and from
controls. Cells were grown at 37C in 5% CO2 in RPMI-1640,
supplemented with 1% of a 200-mM L-glutamine solution plus
15% fetal bovine serum (FBS) (heat inactivated).
RT-PCR with Use of RNA from Lymphoblastoid Cell Lines
Total RNA was isolated from cells by use of TRIzol reagent (In-
vitrogen). cDNA was synthesized with reagents from a SMART
1st strand cDNA synthesis kit (Clontech), and subsequent PCR
reactions were performed with gene-speciﬁc primers designed
from sequence in exons 2 and 6 (forward primer 5′-GGAGGACA-
GATAGCTGCAATG-3′; reverse primer 5′-TCATGGATTCTTGAAA-
TTCTCTCA-3′). PCR fragments were subcloned into a TOPO clon-
ing vector (Invitrogen), and the sequence was veriﬁed.
Exon Trapping
To determine the effect of the various mutant alleles of TRIC
on RNA splicing, the wild-type and mutant alleles were PCR am-
pliﬁed from unaffected and deaf subjects, respectively, within 8.7
kb of genomic DNA encompassing exons 3, 4, and 5 (forward
primer 5′-TCCGTATTCCCTACTCCTCTCTATG-3′; reverse primer
5′-GCCAGATTTTATTCATCCTCTAGATTT-3′). The three exons
and 200 bp of ﬂanking intronic sequence were veriﬁed for all
constructs. For exon-trapping assays, we followed published
protocols.17,18 In brief, each of the constructs was transferred into
pSPL3 (Gibco BRL [no longer commercially available]) and was
transfected into COS-7 cells. Total RNA was isolated from these
cells with use of TRIzol, and cDNAwas synthesized. Nested vector
primers were used, and the PCR fragments were subcloned and
sequenced.
Freeze Fracture
The inner ears were removed from animals after decapitation,
and cochleae were exposed. The oval and round windows were
opened, and a small piece of bone was removed from the cochlear
apex. Fixative (2.5% glutaraldehyde in 0.1 M cacodylate buffer
with 3 mM CaCl2) was gently injected into the inner ear through
these openings, and the entire bulla was then immersed in ﬁx-
ative. Fixation continued for 1.5 h at room temperature, with
gentle, slow rotation. Inner-ear tissue was dissected from the bulla
and was incubated for at least 45 min in 25% glycerol before
mounting on freeze-fracture planchettes and freezing in propane-
isopentane (4:1) cooled in liquid nitrogen. Freeze fracture was
performed in a Balzers BAF400D apparatus by use of standard
procedures19 and was viewed on a JEOL 1200EXII microscope.
Digital images were adjusted in Photoshop 6.0 (Adobe) for op-
timal contrast and brightness.
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Figure 3. Wild-type isoforms of tricellulin, western-blot analysis, and aberrant RNA splice products that are due to mutant alleles of
TRIC. A, Wild-type alternative splice isoforms of human TRIC and mouse Tric. Black bars under exon 2 show the position of the four
predicted transmembrane helices. The red underline (also in panel C) indicates the occludin-ELL domain. The gray rectangles of exons
1 and 2 and of exon 7 are 5′ and 3′ UTRs, respectively. B, Western-blot analyses—through use of anti-tricellulin antibody HL5573 and
protein extracts from adult C57BL/6J mouse pancreas, inner ear, retina, and lung—show a 64-kDa band in all lanes corresponding to
a protein of the predicted size for Tric-a. In the retina, there is an abundant isoform of TRIC that is ∼80 kDa, which is also present at
a lower concentration in lung and inner ear. In protein from lung, there is a 64-kDa band, whereas there are two bands at ∼64 kDa in
protein from the cochlea. The right panel shows a western-blot analysis with a reduced amount of protein loaded on the gel for lung
and a shorter exposure for the lane with protein from the cochlea. C, Aberrant splice products from exon-trapping assays. IVS3-1GrA
causes the use of a cryptic splice-acceptor site within exon 4 of TRIC, which results in the deletion of the ﬁrst 17 nt of exon 4 and a
nonsense mutation (p.C395fsX396). IVS3-1GrA and IVS42TrC cause skipping of exon 4, which results in a frameshift and premature
termination of translation (p.C395fsX403). IVS42delTGAG mRNA uses a cryptic splice-donor site in intron 4 that introduces 23 bp of
intron 4, which results in a premature stop codon (p.K445fsX461). Locations of the mutant alleles are indicated by an asterisk (*).
SDv and SAv are the splice-donor and splice-acceptor sites, respectively, encoded in vector sequence of pSPL3. D, Summary of RT-PCR
data from lymphoblastoid cell lines of normal and (DFNB49) deaf individuals who have splice-site mutations of TRIC. The wild-type
control showed the predicted splicing of exon 4 to exon 5 and alternative splicing of exon 3. mRNA isolated from lymphoblastoid cells
from one deaf subject (each) of families PKDF399, PKDF443, PKDF058, and PKDF340 yielded aberrant splicing, and the locations of
premature stop codons are indicated. Arrowheads indicate the locations of RT-PCR primers.
Antibodies
Tricellulin antiserum (PB705) was raised in rabbit against a syn-
thetic peptide that is conserved inmice and humans (correspond-
ing to residues 119–135 of the mouse sequence [GenBank ac-
cession number DQ682659]). Antiserum was afﬁnity puriﬁed
(AminoLink Plus Immobilization Kit [Pierce]), with the synthetic
peptide used as the immunogen. In addition, antiserum (HL5573)
to amino acids encoded by mouse exons 3 and 4 (residues 212–
282 [GenBank accession number DQ682659]) was generated as
a glutathione S-transferase (GST)–fusion protein. The cDNA was
cloned into pGEX5.1 (Amersham Biosciences), was expressed in
Escherichia coli (BL21GoldDE3pLysS [Stratagene]), was puriﬁed as
described elsewhere,20 and was injected into rabbits (Covance).
To afﬁnity purify antiserum HL5573, the sequence encoding the
same amino acid residues was cloned into pMAL-c2x (New En-
gland Biolabs), transformed into E. coli Rosetta DE3 (Novagen),
and the expressed protein was puriﬁed on amylose resin.21 A col-
umn of MBP-tricellulin (residues 212–282) bound to 4% beaded
agarose (Amino-Link Plus) was then used to afﬁnity purify rabbit
antisera HL5573. Fluorescein-conjugatedmouse anti-occludinan-
tibody and nonconjugated anti-mouse ZO-1 antibody were ob-
tained from Zymed (Carlsbad), and ﬂuorescein-conjugated anti-
rabbit IgG secondary antibody was obtained from Amersham
Pharmacia Biotech.
Speciﬁcity of Antibodies
Antibody speciﬁcity was validated by transfections (Lipofectam-
ine-2000 [Life Technologies]) of GFP-tagged tricellulin into HeLa
cells, followed by immunostaining with PB705 and HL5573 an-
tisera. TRIC-a was subcloned into a pEGFP-C2 vector (Clontech).
Figure 4. Alignment of human tricellulin encoded by TRIC-a and TRIC-b and tricellulin orthologs from ﬁve vertebrates. Black and red bars indicate the predicted transmembrane
helices and occludin-ELL domain, respectively. There is no signiﬁcant amino acid–sequence similarity between TRIC (formerly referred to as “MARVELD2”) and MARVELD1 or MARVELD3
on chromosomes 10 and 16, respectively.
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Figure 5. The predicted protein structure of TRIC-a, the longest isoform encoded by TRIC. Topology of the tricellulin was predicted
by TMpred software. Of the 37 residues, 15 (40.5%) in the ﬁrst extracellular loop are glycine and tyrosine. Red and blue amino acids
indicate negatively and positively charged residues, respectively. The N- and C-termini consist of 31.6% and 41.4% charged residues,
respectively. The position of an arginine codon mutated in family PKDF340 (p.R500X) is shown as a green R. Orange daggers indicate
boundaries of the six coding exons of TRIC. Arrows indicate the locations of translation frameshifts due to splice-acceptor mutation
(IVS3-1GrA) and splice-donor mutations (IVS42TrC and IVS42delTGAG), which occur at codons for residues C395 and K445,
respectively. The red bar indicates the occludin-ELL domain.
HeLa cells were cultured in 10% FBS-supplemented Dulbecco’s
modiﬁed Eagle’s medium. Fluorescence immunocytochemistry
was performed on ﬁxed cells (4% paraformaldehyde, for 15 min).
Immunoﬂourescence stainingwith PB705 andHL5573antibodies
overlapped with the signal produced by GFP-tagged tricellulin
expressed in HeLa cells (data not shown).
Western-Blot Analysis
C57BL/6J mouse pancreas, inner ear, retina, and lung were son-
icated in an ice-cold PBS containing protease inhibitor (Calbio-
chem). Proteins were extracted and denatured by boiling for 5
min in SDS-PAGE sample buffer (0.125 M Tris-HCl, 20% glycerol,
4% SDS, and 0.005% Bromo-phenol blue). A 20-mg protein sam-
ple was separated on a 4%–20% gradient Tris-glycine gel (Novex),
was transferred to a polyvinylidene ﬂuoride (PVDF) membrane,
was blocked overnight with 5% dry milk in tris-buffered sa-
line with Tween (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, and
0.05% Tween 20), and was stained with anti-tricellulin antiserum
(HL5573; 1:2,000 in blocking solution) for 2 h at room temper-
ature. After three washes, the membranes were incubated in a 1:
5,000 dilution of horseradish peroxidase–conjugated anti-rabbit
secondary antibody (Promega) for 30 min and were developed
using the ECL Plus western-blotting detection system (Amersham
Pharmacia Biotech).
Immunostaining
Temporal bones were dissected from C57BL/6 mice, the perilym-
phatic space was gently perfused with 10% trichloroacetic acid
(TCA) through the round to the oval window, and samples were
immersed in 10% TCA for 45 min at 4C and were washed 3 times
with PBS.2 Tissue was then treated with 0.2% Triton X-100 in PBS
for 15 min and was soaked in 1% BSA in PBS. The specimens
were incubated overnight with primary antibodies at 4C and
then were washed three times with PBS, followed by a 30-min
incubation with Alexa Fluor 594– or Alexa Fluor 488–conjugated
secondary antibody. After several washes with PBS, tissue was
mounted using ProLong Antifade (Molecular Probes) and was ob-
served with a confocal microscope (LSM 510 META [Carl Zeiss
MicroImaging]).
Puriﬁcation of GST-Fusion Protein for Binding Assay
GST-fusion proteins encoding human occludin amino acid resi-
dues 371–522 (GST-hDOC371–522), occludin with a point mutation
(hDOC K433D) that abrogates ZO-1 binding, or the entire C-
terminal cytosolic domain of different tricellulin isoforms were
expressed in E. coli BL21 (pLys) and were puriﬁed on glutathione-
agarose as described elsewhere.22 All fusion proteins were clariﬁed
at immediately before use, and concentrations were100,000 g
calculated from the absorbance at A280.
Puriﬁcation of ZO1-N from Insect Cells
High Five cells (Invitrogen) were infected with a bacmid pro-
duced from the pFastBacHTa expression vector encoding amino
acids 1–888 of human ZO-1 (ZO1-N [Genbank accession number
AAA02891]). Cells were harvested 2 d after infection and were
frozen at 80C. To purify the recombinant ZO-1, infected cells
were lysed in 6 volumes of Lysis Buffer (20 mM Tris-Cl [pH 8],
500 mM NaCl, 10% glycerol, 0.8% Igepal CA-630, 12.5 mM im-
idazole, 5 mM 2-mercaptoethanol, and Complete Protease Inhib-
itor Cocktail [Roche Applied Science]), were homogenized with
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Figure 6. Immunoﬂuorescence confocal images from P16 mouse inner-ear epithelia stained with anti-tricellulin pAb PB705 (red) and
anti-occludin FITC-conjugated antibody (green) or mouse anti-Z0-1 mAb (shown in the insets [green]). The left panels represent a
ﬂattened stack of optical z-sections through the cuticular plates of organ-of-Corti hair cells. The middle panels represent an optical
section at the top of round-shaped cuticular plates of vestibular hair cells (white dots) that are surrounded by polygonally shaped apical
portions of supporting cells. The right panels represent an optical section through the apical plasma membrane of the polygonally
shaped marginal cells of the stria vascularis. In the organ of Corti, there are three rows of outer hair cells and one row of inner hair
cells (indicated by an asterisk [*] [left panel]) surrounded by supporting cells. Tricellulin is concentrated at contact points where three
occludin-positive TJs converge in epithelial cells from the organ of Corti (left panels), in vestibular epithelia of the utricle (middle
panels), and in marginal cells of the stria vascularis (right panels). Fainter staining for tricellulin is seen at bTJs (arrow [left panel]).
In hair cells of the organ of Corti, occludin (left panel) and ZO-1 (insets [left panel] and video 1 [online only]) staining intersect
tricellulin at the apical and basal ends of the tricellular junction, which extends downward from the apical surface and spans the entire
depth of the hair-cell cuticular plate (double-headed arrow). In the vestibular epithelia and stria vascularis, tricellulin appears to be
colocalized also with Z0-1 at the apical end of the tricellular junctions (insets [middle and left panels]). Scale mm.barsp 5
20 strokes of a dounce homogenizer, and were centrifuged at 4C
for 10 min at . The soluble supernatant was combined20,000 g
with HIS-Select HF Nickel Afﬁnity Gel (25 ml resin/ml lysate) and
was incubated for 30 min at 4C. Beads were washed twice in 20
volumes of Buffer I (20 mM Tris-Cl [pH 8], 200 mM NaCl, 10%
glycerol, 0.2% Igepal CA-630, 12.5 mM imidazole, and 5 mM 2-
mercaptoethanol), twice in Buffer II (20 mM Tris-Cl [pH 8], 100
mMNaCl, 10% glycerol, 0.5% Igepal CA-630, 12.5mM imidazole,
and 5 mM 2-mercaptoethanol), and received a ﬁnal wash in bind-
ing buffer (PBS with 10% glycerol, 12.5 mM imidazole, and 5mM
2-mercaptoethanol). The concentration of protein on the beads
was estimated by eluting protein in 125 mM imidazole from a
known quantity of beads and measuring the A280 of the eluate.
Tricellulin-Binding Assays
ZO1-N immobilized on agarose (0.5 mM) or agarose beads alone
were mixed with 5.0 mM of the respective GST-fusion protein in
a ﬁnal volume of 0.5 ml and were incubated overnight at 4C.
The beads were washed four times in binding buffer, and the
bound proteins were eluted in 100 ml of PBS containing 125 mM
imidazole. The eluate was diluted in 100 ml sample buffer, was
resolved by SDS-PAGE, and was stained with Coomassie Brilliant
Blue.23 Destained gels were scanned with an Odyssey Infrared
Imaging System (LI-COR Biosciences).
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Figure 7. Freeze-fracture images of inner ear tTJs. A, At the apical end of an outer hair cell (OHC) in the organ of Corti of an adult
guinea pig, the fracture has run across the apical membrane, cross-fracturing the bases of the stereocilia in the W-shaped bundle. At
the border of the outer hair cell, where it would have contacted supporting cells, the fracture runs at 90 to the apical surface. The
fracture exposes the whole depth of the hair cell tTJ down the lateral plasma membrane (arrow). The drawing shows TJ strands at the
level of the most apical part of the lateral membrane (vertical red bars indicate the length of the tTJ; green lines represent ZO-1 staining
outlining the cuticular plate at the top and bottom) (see ﬁg. 6 [left panels]). B, The tTJ (arrow) at the site of contact of an outer
hair cell with two supporting cells (1 and 2) is a distinct ridge from which short strands extend zipperlike to either side. C, For the
mouse utricular macula, tTJs are less complex than those of an outer hair cell but also appear zipperlike. D, For the marginal cells of
the stria vascularis, the tTJs appear similar to those of conventional epithelial cells such as Eph4 cells.13 Scale mm.barsp 5
Results
Elsewhere, we reported two Pakistani families segregating
moderate-to-profound hearing loss consistent with link-
age toDFNB4914 (ﬁgs. 1A and 2).Meiotic information from
six additional families reﬁned the disease-linked haplo-
type to 2.4 Mb (ﬁg. 1B). This interval has 33 annotated
genes. We sequenced the reported exons of nine genes—
TRIC, which encodes tricellulin13 (formerly referred to as
“MARVELD2”), OCLN,24,25 GTF2H2, SMA3, SMA4, TAF9,
RAD17, SLC30A5, and KENA—using genomic DNA from
two affected members of each of the eight DFNB49-
affected families. We found pathogenic mutations only
in TRIC (table 1). In humans, the longest TRIC mRNA
(TRIC-a) has seven exons (GenBank accession number
DQ682656), which are predicted to encode four trans-
membrane domains and an occludin-ELL domain (Pfam
accession number PF07303) located at the C-terminus (ﬁg.
3A).
Affected individuals from families PKDF141, PKSR12,
PKDF462, and PKDF443 (ﬁg. 1A and 1B) are homozygous
for the same disease haplotype and have the same transi-
tionmutation—TRIC (IVS42TrC)—located in the splice-
donor site of exon 4 of TRIC (ﬁg. 1C). Families PKDF058
and PKDF156 segregate a deletion (IVS42delTGAG) of
this same splice-donor site, and family PKDF399 segre-
gates amutation in the splice-acceptor site of exon 4 (IVS3-
1GrA). Affected members of family PKDF340 are homo-
zygous for a transition mutation (c.1498CrT) that creates
a nonsense codon, p.R500X, in exon 5 of TRIC, which
predicts a truncation within the occludin-ELL domain (ﬁg.
1C). All of these recessive mutations of TRIC cosegregate
with hearing loss in the families. None of these mutations
were detected in a total of 443 normal-hearing subjects
from Pakistan ( ), India ( ), and the Humannp 263 np 90
Variation Panel ( ) (Coriell Cell Repositories) (tablenp 90
1).
The longest isoform of TRIC is TRIC-a, which we de-
tected in human fetal cochlear mRNA by RT-PCR. TRIC-a
is predicted to encode a protein of 558 aa, whereas the
TRIC-a1 (GenBank accession number DQ682657)message
lacks exon 3 (ﬁgs. 3A, 4, and 5). At the C-terminus of the
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Figure 8. The binding of tricellulin to ZO-1, disrupted in p.R500X-
truncated tricellulin. Proteins were resolved by SDS-PAGE and were
stained with Coomassie Brilliant Blue. Top panel, lane 1, Control
has only the N-terminal half of ZO-1 immobilized on agarose beads
(ZO1-N; amino acids 1–888). Lanes 2 and 3, GST-fusion proteins
encoding the corresponding domains of hDOC (amino acids 371–
522) and a mutant occludin (hDOC K433D) that cannot bind to
ZO1-N, used as positive and negative controls, respectively.15 Lanes
4–7, GST-fusion proteins encoding TRIC-a and TRIC-a1 bind ZO1-
N, whereas truncated tricellulin, because of p.R500X, has reduced
binding to ZO1-N. Compare lanes 4 and 5 with lanes 6 and 7. The
puriﬁed ZO1-N fusion protein (arrowhead) was also resolved for
comparison; there is little, if any, degradation of fusion proteins
detected after binding. Middle panel, Puriﬁed GST-fusion proteins
carried through the binding assay without ZO1-N. Bottom panel,
Little or no binding of fusion proteins to agarose alone. The mo-
lecular weight markers are shown in kilodaltons.
TRIC-a and TRIC-a1 isoforms, there is a 103-aa residue
occludin-ELL domain that is 32% identical (51% similar)
to a region of the C-terminus of occludin. In contrast,
TRIC-b is a shorter isoform (GenBank accession number
NM144724) that was reported to be cloned from human
lung, mammary gland, and eye mRNA and encodes 458
aa lacking the occludin-ELL domain (ﬁg. 3A). TRIC-c (Gen-
Bank accession number DQ682658), which encodes 442
aa, was cloned from mRNA isolated from human lung.
In this isoform, exon 2 is alternatively spliced and en-
codes only two predicted transmembrane helices (ﬁg.
3A). From RNA isolated from the mouse cochlea, similar
isoforms of tricellulin were found (Tric-a, Tric-b, and Tric-
c [GenBank accession numbers DQ682659, DQ682660,
and DQ682661, respectively). Western-blot analyses of
proteins isolated from various mouse tissues show the ex-
pected size bands corresponding to tricellulin isoforms
(ﬁg. 3B).
Exon-trapping assays were performed to determine the
effects of the three different splice-site mutations on TRIC
mRNA processing. A wild-type TRIC construct produced
the expected splice products (ﬁg. 3C), whereas each of the
splice-site mutant constructs produced only aberrantly
spliced RNAs with premature stop codons (ﬁg. 3C). To
determine whether these or other aberrant splice variants
occur in vivo, RNA was isolated from lymphoblastoid cell
lines of affected subjects, each homozygous for one of the
three splice-site mutations. RT-PCR analyses of transcripts
from these lymphoblastoid cell lines resulted only in aber-
rantly spliced products (15 clones evaluated for each cell
line), 2 of which were also found in the exon-trapping
experiments (ﬁg. 3D). By comparison, lymphoblastoid cells
from a control subject with a wild-type sequence for TRIC
produced wild-type isoforms of TRIC with and without
alternatively spliced exon 3 (ﬁg. 3D). mRNA for TRIC was
also recovered from a lymphoblastoid cell line from a deaf
individual who is homozygous for p.R500X; thus, at least
some R500X mRNA escapes degradation by the nonsense-
mediated decay pathway27 (ﬁg. 3D).
In postnatal day 5 (P5), P10, P16, and P90 mouse inner
ears, which were counterstained with anti-occludin and
ZO-1 antibodies, tricellulin was found to be concentrated
at tricellular points of contact in the majority of epithelial
cells of the cochlea and vestibule, and a weaker punctate
signal was observed along the bTJs (ﬁg. 6 and data not
shown). At the junctions of outer hair cells with two ad-
jacent supporting cells, we observed tricellulin immuno-
reactivity along the entire depth of tricellular junctions,
extending in near-perpendicular orientation to the retic-
ular lamina, as far down as the depth of the hair-cell cu-
ticular plate (an actin-rich structure into which stereocilia
rootlets are embedded) highlighted by the anti-occludin
antibody (ﬁg. 6). Tricellulin appears to intersect, at an∼90
angle, the perimeter of the two rings of ZO-1 that outline
the top and the bottom of the cuticular plate (ﬁg. 6 [insets
in the left panel] and video 1 [online only]). Tricellulin
immunoreactivity also spans the entire depth of tTJs of
other epithelial cell types as well, although the tTJs of the
nonsensory epithelium do not appear as deep as the tTJs
of the sensory epithelium of the organ of Corti (ﬁg. 6).
Freeze-fracture replica electron microscopy shows that,
in the organ of Corti (ﬁg. 7A and 7B), tricellular junctions
have an elaborate structure, characterized by a long ridge
resembling a zipper, oriented perpendicular to the apical
surface (ﬁg. 7). The tTJs of the vestibular sensory epithe-
lium (ﬁg. 7C), although relatively deep, are not as complex
as those of hair cells of the organ of Corti. By comparison,
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the tricellular junctions of the stria vascularis (ﬁg. 7D) are
not as deep and are similar to the central sealing elements
of tTJs observed in cells derived from themousemammary
gland (Eph4 cells) and other nonsensory epithelial cells.13
The C-terminal domain of occludin is known to bind
the scaffolding protein ZO-1, which controls its targeting
to the cell-cell junctions.15 The high-resolution structure
of this domain has been determined,15 and sequence com-
parison with the occludin-ELL domain of tricellulin in-
dicates that tricellulin contains all the structural elements
and several speciﬁc surface residues required for binding
to ZO-1. Therefore, we examined the ability of GST-fusion
proteins encoding the cytosolic C-terminal domains of
different tricellulin isoforms to bind in vitro to puriﬁed
ZO-1. We found that wild-type tricellulin, like a C-terminal
fragment of occludin containing the human occludin-ELL
domain residues (hDOC), binds in vitro directly to the ZO-
1 polypeptide. In contrast, binding of the p.R500Xmutant
tricellulin protein to ZO-1 was signiﬁcantly compromised
(ﬁg. 8).
Discussion
Epithelial cell sheets separate ﬂuid-ﬁlled compartments of
polarized tissues. Within these sheets, intercellular junc-
tional complexes composed of adherens junctions and
desmosomes serve to mechanically link adjacent cells. TJs
are continuous beltlike strands or ﬁbrils11,28 that encircle
the cell near the apical surface and create a semipermeable
paracellular seal.29 TJs are composed of many proteins, in-
cluding occludin24,25 and one ormoremembers of the large
family of claudins.30 Claudins are tetraspan integral mem-
brane proteins that contribute to charge and size-selective
pores of the paracellular barrier.31–33 Both claudins and oc-
cludin are associated with one or more members of the
MAGUK family of scaffolding proteins—including ZO-1,
-2, and -3—and these interactions are important for the
assembly of TJs.34
TRIC encodes tricellulin, a newly discovered TJ pro-
tein,13 which is ubiquitously expressed in epithelial junc-
tions of tissues and organs throughout the body. When
tricellulin is down-regulated by RNAi (RNA interference),
cells become electrophysiologically compromised and both
the tTJs and bTJs are disorganized.13 Yet the only obvious
phenotype of mutant alleles of TRIC is deafness. It is pos-
sible that some other molecule compensates for the ab-
sence of wild-type tricellulin in other epithelial cell types
but not in the inner ear. Alternatively, the exon 4 splice-
site mutant alleles (IVS3-1GrA, IVS42TrC, and IVS4
2delTGAG) associated with deafness do produce, in vivo,
a small amount of wild-type TRIC message and protein
sufﬁcient for tricellular-junction function in other epithe-
lial cells but not in the inner ear. This seems unlikely, since
we did not detect wild-type TRIC mRNA either in our
exon-trapping experiments or in lymphoblastoid cell lines
derived from affected individuals. A third possibility is
that the wild-type short isoform of tricellulin (e.g., TRIC-
b) may be present in many tissues and may be sufﬁciently
functional for these tricellular junctions. However, TRIC-
b–encoded protein should not bind ZO-1. Perhaps this
binding activity is absolutely required for tTJs in the inner
ear but not in other epithelia. A fourth possibility is that
mutant, truncated tricellulin protein, if synthesized in
vivo, provides a sufﬁciently tight barrier for intermediate-
to-tight junctions in many epithelial tissues but is not able
to maintain the unusually high tightness of the TJs of the
organ of Corti.
A common feature of the four DFNB49 tricellulin alleles
is that they encode predicted truncated proteins that lack
the ability to bind to the scaffolding protein ZO-1, and
probably to ZO-2 and ZO-3 as well, because of the loss
of the conserved C-terminal occludin-ELL domain. Mu-
tations in the same domain in occludin can interfere with
the localization to TJs.15 Thus, it is interesting to speculate
that at least one underlying cause of cellular dysfunction
in the cochlea is the inability to incorporate these mutant
tricellulin proteins into the cytosolic scaffold formed by
ZO proteins. Fanning and coauthors reported that ZO-1
can directly bind to F-actin–linking transmembrane pro-
teins, such as occludin and claudins, to the actin cyto-
skeleton.35 In this regard, the tTJs of hair cells may be
attached intracellularly to cytoskeletal actin of the cutic-
ular plate into which stereocilia rootlets are embedded.
Therefore, a possible reason for the deafness phenotype
due to mutations of TRIC is that the reticular lamina in
the organ of Corti is less rigid, leading either to abnor-
malities in stereocilia microdeﬂections or to the inability
of the reticular lamina to withstand the mechanical stress
of outer hair–cell motility. These ideas can be tested in a
mouse model of DFNB49, but elucidating the function of
tricellulin in other tissues will require strategies that se-
lectively and individually remove each of the tricellulin
isoforms.
Dysfunction of endothelial or epithelial bTJ barriers is
associated with a variety of inherited and neoplastic dis-
orders,5,6,836–42 as well as with pathological processes caused
by certain infectious pathogens.43 To date, mutant alleles
of TRIC are the only known cause of compromised tri-
cellular junctions of epithelial cells. Further study of tri-
cellulin could help to provide a rational molecular frame-
work useful for engineering novel therapeutic agents that
could effectively target and modulate bTJs and tTJs.
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Appendix A
Video 1. The 3D reconstruction of the series of optical z-sections
through the cuticular plates of organ of Corti outer hair cells. The
video (a .MOV ﬁle [online only] that can be viewed with QuickTime
[available at the Apple Web site]) shows three rows of outer hair
cells surrounded by supporting cells. Tricellulin (red) is concen-
trated at contact points where three bTJs outlined by ZO-1 staining
(green) converge in epithelial cells from the organ of Corti. ZO-1
(green) and occludin (shown in ﬁg. 6) staining intersect tricellulin
at the apical and basal end of the tricellular junction, which ex-
tends downward from the apical surface and spans the entire depth
of the hair-cell cuticular plate. The 3D reconstruction was created
using LSM510 software (Carl Zeiss MicroImaging).
Web Resources




GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for resi-
dues 119–135 [accession number DQ682659] and 212–
282 [accession number DQ682659], ZO1-N [accession num-
ber AAA02891], and exons for TRIC-a [accession number
DQ682656], TRIC-a1 [accession number DQ682657], TRIC-
b [accession number NM144724], TRIC-c [accession number
DQ682658], Tric-a [accession number DQ682659], Tric-b [ac-
cession number DQ682660], and Tric-c [accession number
DQ682661])
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for DFNB29)
Pfam, http://www.sanger.ac.uk/Software/Pfam/ (for occludin-ELL
[accession number PF07303])
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